Northpond Ventures — 2019 Investments
3 investments dated 2019 · listed companies and verified rows first · show all
908 Devices manufactures handheld mass spectrometry and chemical analysis devices for rapid detection in defense, security, and hazardous materials response applications.
Deep TechDefense TechHardwareMedical DevicesBoston, US
Kevin J. Knopp, PhD(CEO & Co-founder)Christopher Brown(Executive Officer)Kevin Knopp(Executive Officer, Director)Joseph Griffith IV(Executive Officer)
BoardKevin Hrusovsky(Director)Corey Steffek(Director)
Board seatSharon Kedar· per SEC Form D · $17.5M raise · filed Apr 2019
Co-investorsARCH Venture PartnersRazor's Edge VenturesUTECAramco Ventures
Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inXiaowei Zhuang(Founder; Professor, Harvard University)inFenel Eloi(Director)Robert Carson(Executive Officer, Director)Rob Carson(Chief Executive Officer)in
Board seatSharon Kedar· per SEC Form D
Co-investorsARCH Venture Partners6 Dimensions CapitalApplied VenturesKilonova CapitalPura Vida InvestmentsRazor's Edge Ventures+2 more
Boston, US
Board seatSharon Kedar· per SEC Form D · $20M raise · filed Mar 2020
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.